Evommune, Inc.
Prices may be delayed up to 15 min. Not investment advice. News volume: articles in the 4Search index each day.
Key statistics
Against its peers
Compare in full ›| EVMN | EVAX | EDSA | ALXO | EVGN | IMUX | |
|---|---|---|---|---|---|---|
| Market cap | 219.20M | 26.79M | 29.32M | 188.06M | 6.41M | 108.34M |
| P/E (TTM) | — | — | — | — | — | — |
| Forward P/E | -1.7 | -198.0 | — | -2.5 | -0.6 | -3.4 |
| Price/book | 0.8 | 2.6 | 52.9 | 1.4 | -1.5 | 0.8 |
| Dividend yield | — | — | — | — | — | — |
| 1-year change | −70.14% | −52.56% | +27.65% | +15.25% | −68.97% | +13.27% |
| Today | +1.68% | +0.34% | −4.82% | +5.43% | +1.25% | +4.47% |
The closest companies by business and industry (Biotechnology). Prices may be delayed up to 15 min.
Latest news
All EVMN news ›Evommune (NYSE:EVMN) Stock Bumped Up to "Hold" by UBS Group
Evommune (NYSE:EVMN - Get Free Report) was upgraded by equities research analysts at UBS Group to a "hold" rating in a note issued to investors on Sunday, Zacks reports. View Our Latest Stock Analysis on Evommune NYSE EVMN opened at $5.87…
Analysts Have Conflicting Sentiments on These NA Companies: Fiserv (FISV), SpyGlass Pharma (Nasdaq: SGP) and Evommune, Inc. (EVMN)
Analysts have been eager to weigh in on the NA sector with new ratings on Fiserv (FISV), SpyGlass Pharma (SGP) and Evommune, Inc. (EVMN). Wells Fargo analyst Jason Kupferberg maintained a Hold rating on Fiserv today and set a price target…
From the 4Search news index, newest first.
In the news
Mentioned with
People in the coverage
Themes
Most coverage from
- marketbeat.com1
- markets.businessinsider.com1
Finance and business coverage in the 4SEARCH.business news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 2 articles, not a forecast.